한글목차

분기 병변 세계 시장 규모는 2024년 27억 6,000만 달러로 평가되었습니다. 예측 기간 동안 40억 2,000만 달러에 달할 것으로 예상되며, 2030년까지 6.43%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.

세계 분지 병변 시장은 주요 동맥이 두 갈래로 갈라져 발생하는 분지 병변의 진단과 치료에 초점을 맞춘 의료 산업의 전문 부문을 포괄합니다.

분지 병변 세계 시장은 혈관, 특히 관상동맥의 분지 병변이 야기하는 문제를 해결하기 위한 의료기기, 시술 및 치료법을 다루고 있습니다. 이러한 병변은 혈류를 제한하고 심혈관 합병증을 유발할 수 있습니다.

주요 시장 성장 촉진요인

심혈관 질환의 유병률 증가

주요 시장 이슈

분지 병변 치료의 복잡성

규제와 상환의 장애물

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 분지병변 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 용도별(말초, 관상동맥)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 분지병변 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 캐나다
  • 멕시코

제7장 유럽의 분지병변 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 분지병변 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 분지병변 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 분지병변 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트
  • 터키
  • 이집트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병(M&A)

제13장 세계의 분지병변 시장 : SWOT 분석

제14장 경쟁 구도

• Boston Scientific Corp.
• Abbott Laboratories Inc.
• Cardinal Health Inc.
• Medtronic Plc
• C. R. Bard, Inc.(Becton, Dickinson and Company)
• Johnson & Johnson Services, Inc.
• Spectranetics Corp(Philips Healthcare)
• Terumo Medical Corp.
• Poseidon Medical Inc.

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

영문목차

Global Bifurcation Lesions Market was valued at USD 2.76 billion in 2024 and is expected to reach USD 4.02 Billion in the forecast period with a CAGR of 6.43% through 2030. The Global Bifurcation Lesions Market encompasses a specialized segment of the medical industry focused on the diagnosis and treatment of bifurcation lesions, which occur when a major artery divides into two smaller branches.

The Global Bifurcation Lesions Market deals with medical devices, procedures, and therapies aimed at addressing the challenges posed by bifurcation lesions in blood vessels, particularly in coronary arteries. These lesions can restrict blood flow, leading to cardiovascular complications.

Key Market Drivers

Increasing Cardiovascular Disease Prevalence

The increasing prevalence of cardiovascular diseases (CVDs) serves as a significant market driver propelling the growth of the Global Bifurcation Lesions Market. Cardiovascular diseases, encompassing conditions like coronary artery disease, heart attacks, and angina, are a leading cause of morbidity and mortality globally. The World Health Organization (WHO) reports that CVDs are responsible for over 17 million deaths annually, making them the leading cause of death worldwide. As lifestyles become more sedentary, diets less healthy, and populations age, the burden of CVDs is projected to continue increasing. Bifurcation lesions are a subset of cardiovascular conditions in which plaque buildup or blockages occur at the junctions where major arteries split into smaller branches. Such lesions can lead to severe complications, including heart attacks and reduced blood flow to vital organs. As the prevalence of CVDs increases, so does the incidence of bifurcation lesions, driving the demand for specialized treatments. According to Centers for Disease Control and Prevention, Heart disease is the leading cause of death for both men and women, as well as for individuals across most racial and ethnic groups. Every 33 seconds, someone dies from cardiovascular disease. In 2022 alone, heart disease was responsible for 702,880 deaths, accounting for roughly one in every five deaths.

Key Market Challenges

Complexity of Bifurcation Lesion Treatment

Bifurcation lesions pose a unique set of challenges due to the branching of blood vessels. These complexities include variable lesion morphologies, side branch ostial stenosis, and the risk of restenosis at the bifurcation point. Treating these lesions requires specialized techniques, tools, and stents, which can be challenging for healthcare providers. Additionally, the need for expert knowledge and training in bifurcation lesion management can limit the number of physicians who can effectively perform these procedures, potentially slowing down market growth.

Regulatory and Reimbursement Hurdles

Medical devices and procedures in the cardiovascular field, including those used for bifurcation lesion treatment, are subject to stringent regulatory requirements and approvals. Obtaining regulatory clearance or approval can be a time-consuming and costly process. Furthermore, reimbursement policies vary by region, and reimbursement challenges can affect the adoption of newer and more advanced technologies. Limited or delayed reimbursement for these procedures can discourage healthcare providers from offering them, which can hinder market expansion.

Key Market Players

• Boston Scientific Corp.
• Abbott Laboratories Inc.
• Cardinal Health Inc.
• Medtronic Plc
• C. R. Bard, Inc (Becton, Dickinson and Company)
• Johnson & Johnson Services, Inc.
• Spectranetics Corp (Philips Healthcare)
• Terumo Medical Corp.
• Poseidon Medical Inc

Report Scope:

In this report, the Global Bifurcation Lesions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bifurcation Lesions Market, By Application:

• Peripheral
• Coronary

Bifurcation Lesions Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bifurcation Lesions Market.

Available Customizations:

Global Bifurcation Lesions market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bifurcation Lesions Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Peripheral, Coronary)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America Bifurcation Lesions Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bifurcation Lesions Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
  • 6.3.2. Canada Bifurcation Lesions Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
  • 6.3.3. Mexico Bifurcation Lesions Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application

7. Europe Bifurcation Lesions Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bifurcation Lesions Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
  • 7.3.2. United Kingdom Bifurcation Lesions Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
  • 7.3.3. Italy Bifurcation Lesions Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
  • 7.3.4. France Bifurcation Lesions Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
  • 7.3.5. Spain Bifurcation Lesions Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application

8. Asia-Pacific Bifurcation Lesions Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bifurcation Lesions Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
  • 8.3.2. India Bifurcation Lesions Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
  • 8.3.3. Japan Bifurcation Lesions Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
  • 8.3.4. South Korea Bifurcation Lesions Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
  • 8.3.5. Australia Bifurcation Lesions Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application

9. South America Bifurcation Lesions Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bifurcation Lesions Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
  • 9.3.2. Argentina Bifurcation Lesions Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
  • 9.3.3. Colombia Bifurcation Lesions Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application

10. Middle East and Africa Bifurcation Lesions Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bifurcation Lesions Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
  • 10.3.2. Saudi Arabia Bifurcation Lesions Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
  • 10.3.3. UAE Bifurcation Lesions Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
  • 10.3.4. Kuwait Bifurcation Lesions Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Application
  • 10.3.5. Turkey Bifurcation Lesions Market Outlook
    • 10.3.5.1. Market Size & Forecast
      • 10.3.5.1.1. By Value
    • 10.3.5.2. Market Share & Forecast
      • 10.3.5.2.1. By Application
  • 10.3.6. Egypt Bifurcation Lesions Market Outlook
    • 10.3.6.1. Market Size & Forecast
      • 10.3.6.1.1. By Value
    • 10.3.6.2. Market Share & Forecast
      • 10.3.6.2.1. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Bifurcation Lesions Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Boston Scientific Corp.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Key Personnel
  • 14.1.5. SWOT Analysis
  • 14.1.6. Financials (As Reported)
• 14.2. Abbott Laboratories Inc.
• 14.3. Cardinal Health Inc.
• 14.4. Medtronic Plc
• 14.5. C. R. Bard, Inc.(Becton, Dickinson and Company)
• 14.6. Johnson & Johnson Services, Inc.
• 14.7. Spectranetics Corp (Philips Healthcare)
• 14.8. Terumo Medical Corp.
• 14.9. Poseidon Medical Inc.

15. Strategic Recommendations

16. About Us & Disclaimer